dr. vogelzang discusses mortalities in cabozantinib trial
Published 13 years ago • 878 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:34
dr. vogelzang discusses the cabozantinib trial design
-
1:35
dr. vogelzang discusses cabozantinib trial design
-
1:45
dr. vogelzang discusses cabozantinib's dose size
-
0:56
dr. vogelzang on cabozantinib clinical trial results
-
1:14
dr. vogelzang describes cabozantinib's side effects
-
21:55
dr christian frezza - mitochondrial dysfunction in cancer
-
11:13
for patients: how cabometyx® (cabozantinib) may work
-
52:04
innate lymphoid cell/eosinophil collaboration re-shapes melanoma outcomes by dr. gabrielle belz
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
1:34
dr. vogelzang discusses prospect trial for prostate cancer
-
2:22
nicholas vogelzang, md, discusses re-emergence of dose reduced cabozantinib alezotuzumab in apc
-
1:04
nicholas j. vogelzang, md, discusses the difference in mortality in the prosper and spartan trials
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer
-
1:11
dr. vogelzang on xl184's effect on bone metastases
-
6:00
clinical rationale for cabozantinib in hcc
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
3:07
dr. vogelzang discusses the addition of chemotherapy to adt in men with prostate cancer
-
1:27
dr. ezra cohen on the efficacy and pharmacokinetics of cabozantinib
-
2:31
dr. nicholas vogelzang discusses latest advances in prostate cancer
-
1:53
dr. nicholas vogelzang discusses sequencing abiraterone and enzalutamide
-
1:46
what is the next big thing in kidney cancer care and treatment?
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib